Latex Allergy: What It Is, Causes, Symptoms & Treatments
TUESDAY, May 9, 2023 -- Having a latex allergy is no fun, but it can be a real challenge for health professionals who have to work with a wide variety of medical equipment that can contain the allergen.
Latex allergy can trigger a range of symptoms,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 9, 2023 Category: General Medicine Source Type: news
Cochrane Denmark and CEBMO seek Postdoc in Evidence-Based Medicine
A full-time position as a Postdoc is vacant at Cochrane Denmark and at the Centre for Evidence-Based Medicine Odense (CEBMO),Department of Clinical Research,Faculty of Health Sciences,University of Southern Denmark (SDU).Apply by 1 July 2023The position is limited to two years with the possibility of extension by up to a maximum of two years, starting in September 2023 (negotiable).The position involves research (50%), pre-graduate and postgraduate guidance and teaching (40%) and administration (10%).Research tasksThe position as a postdoc consists of research, teaching, professional development, and guidance in Evidenc...
Source: Cochrane News and Events - May 9, 2023 Category: Information Technology Authors: Lydia Parsonson Source Type: news
Warburg and Advent in the lead to acquire Baxter's biopharma unit
A private equity consortium comprising Warburg Pincus and Advent International is in advanced talks to acquire medical device maker Baxter International Inc's (BAX.N) biopharma solutions business in a deal that could reach or exceed $4 billion, people familiar with the matter said on Sunday.…#warburgpincus #adventinternational #advent #baxter #warburg #thermofisher #medtronicplc #davidcarnevali #anirbansen #dianecraft (Source: Reuters: Health)
Source: Reuters: Health - May 8, 2023 Category: Consumer Health News Source Type: news
HAPPE Spine Announces FDA Clearance for the INTEGRATE-C(TM) Interbody Fusion System
GRAND RAPIDS, Mich., May 8, 2023 -- (Healthcare Sales & Marketing Network) -- HAPPE Spine, a medical device company focused on bringing innovative materials to orthopaedic implants, announces that the company's INTEGRATE-C Interbody Fusion System has rec... Devices, Orthopaedic, Neurosurgery, FDA HAPPE Spine, INTEGRATE-C, Interbody Fusion, spine surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 8, 2023 Category: Pharmaceuticals Source Type: news
Govt to discuss TMR with pharma bodies on May 16
In this regard, the Department of Pharmaceuticals (DoP) and the National Pharmaceutical Pricing Authority (NPPA) have invited members of pharma associations and medical device manufacturers for the meeting and sought their suggestions by Friday. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - May 5, 2023 Category: Pharmaceuticals Source Type: news
J & J consumer products spinoff Kenvue goes public through $3.8B IPO
J&J spun off its consumer health division in order to "streamline" operations and focus on its pharmaceutical and medical device divisions. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 4, 2023 Category: Biotechnology Authors: John George Source Type: news
Medical Device Maker Stryker Faces New Bribery Concerns
Medical-device maker Stryker disclosed an investigation by U.S. authorities into potential violations of antibribery law, the third such probe into the company in the past decade. In a securities filing this week, the Kalamazoo, Mich.-based company said it was contacted by the U.S. Justice…#stryker #kalamazoo #usjusticedepartment (Source: Reuters: Health)
Source: Reuters: Health - May 4, 2023 Category: Consumer Health News Source Type: news
A Community Is Enabled Through the Reuse of Walkers, Wheelchairs and More
Describes a project at the University of Kentucky Center of Excellence in Rural Health to address accessibility needs of the disabled Kentuckians. The program uses service-learning with physical therapy students and high school students to refurbish medical equipment and toys for the uninsured, underinsured, and other underserved populations. Success from the program led to additional funding streams and the ability to expand the program to include training, education, demonstrations, and more. (Source: News stories via the Rural Assistance Center)
Source: News stories via the Rural Assistance Center - May 3, 2023 Category: Rural Health Source Type: news
Apple escapes a trade secret verdict over a key smartwatch feature that could have cost the company as much as $1.85 billion
Apple and Masimo failed to persuade a jury to reach a unanimous verdict in a trial where the medical-devices company claimed a blood-oxygen sensor in the Apple Watch was developed using misappropriated trade secrets. Masimo sought as much as $1.85 billion, claiming that was the amount of illegal…#apple #applewatch #santaana #iphone #jamesselna #masimocorp #cercacor #timcook #josephre #joemueller (Source: Reuters: Health)
Source: Reuters: Health - May 2, 2023 Category: Consumer Health News Source Type: news
Brisbane ‘body sculpting’ company accused of spreading lie that rival hired pretty women to seduce MDs
A Bay Area medical-device company is accused in a new lawsuit of spreading lies about a rival, including that it “hired good-looking female sales representatives to sleep with doctors in order to sell products.” Cutera, a Brisbane firm making lasers and other equipment for “body sculpting,” skin…#bayarea #lutronicaesthetics #massachusetts #lutronic #sanmateocounty #superiorcourt #hollywood #sacramento #icloud #kimberlymueller (Source: Reuters: Health)
Source: Reuters: Health - May 1, 2023 Category: Consumer Health News Source Type: news
Maker of fast coronavirus tests chops hundreds of Bay Area jobs
SUNNYVALE — A maker of rapid coronavirus tests has revealed plans to chop hundreds of jobs in the Bay Area, a grim disclosure that suggests tech and biotech layoffs in the region have yet to run their course. Cepheid, a medical devices and biotech company, has told state labor officials that it…#sunnyvale #bayarea #cepheid #newark #fremont #santaclara #warn #edd #sanjose #sanjoaquincounty (Source: Reuters: Health)
Source: Reuters: Health - April 28, 2023 Category: Consumer Health News Source Type: news
Medpace, A Top 1% Earnings Stock, Just Crushed Expectations
easily beat Wall Street's first-quarter projections and boosted its full-year outlook, and MEDP stock rocketed early Tuesday. X Medpace is a contract research organization, or CRO. It helps companies run the clinical studies they need to gain approval of new drugs and medical devices. During the…#medp #xmedpace #cro #medpace #marketsmithcom #epsrating #compositerating #ibddigital #allisongatlin #ibdagatlin (Source: Reuters: Health)
Source: Reuters: Health - April 25, 2023 Category: Consumer Health News Source Type: news
" Off-Label " and Investigational Use Of Marketed Drugs, Biologics, and Medical Devices
"Off-Label" Investigational Use Of Marketed Drugs, Biologics, and Medical Devices - Information Sheet (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 25, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Antibody Drug Conjuagates (ADCs) Approved by FDA
The large number of emerging antibody-drug conjugates (ADCs) for cancer therapy has resulted in a significant market‘boom’, garnering worldwide attention. With significant technological advancements and an improved mechanisticunderstanding of ADC activity, after decades of research, 14 ADCs have been FDA approved, each providing demonstrabletherapeutic benefit to cancer patients. Currently, about 297 ADCs are in preclinical/clinical development, indicating that theworld is...This story is related to the following:Biopharmaceuticals (Source: Industrial Newsroom - Health, Medical and Dental Supplies)
Source: Industrial Newsroom - Health, Medical and Dental Supplies - April 25, 2023 Category: Medical Devices Source Type: news
FDA: Authorization of Emergency Use of a Medical Device During COVID-19; Availability
The Food and Drug Administration announces an Emergency Use Authorization for BioSynchronicity Corporation's C-Sync COVID –19 Antigen Test. The authorization is effective March 24, 2023. (Source: Federal Register updates via the Rural Assistance Center)
Source: Federal Register updates via the Rural Assistance Center - April 25, 2023 Category: Rural Health Source Type: news
